글로벌 요독증 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 요독증 치료 시장

요독증 치료 시장은 2021년에서 2028년까지의 예측 기간 동안 5.90%의 시장 성장을 목격할 것으로 예상됩니다. Data Bridge Market Research의 요독증 치료 시장 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 신장 질환 유병률이 증가함에 따라 요독증 치료 시장 성장이 가속화되고 있습니다.

요독증은 신장 기능의 악화와 관련된 임상적 상태를 말합니다. 이 상태는 대사 이상과 함께 체액, 전해질 및 호르몬 불균형과 같은 증상을 보입니다. 이 신장 질환의 문자적 의미는 "혈액 내 소변"입니다. 이 질환은 일반적으로 만성 및 말기 신장 질환(ESRD) 환경에서 발생하는 경향이 있습니다. 이 상태는 또한 급성 신장 손상의 결과로 인해 발생합니다.

The increase in the incidences of uremia among the population across the globe acts as one of the major factors driving the growth of the uremia treatment market. The rise in the level of people suffering from chronic disorders such as diabetes and high blood pressure among others and surge in the prevalence of end-stage renal disease, causing the development of uremia among people and increase the number of kidney transplants accelerate the market growth. The high need for the drugs associated with treating the complications caused by the disorder and the increase in initiatives taken by public organizations to develop drugs for the disorder further influence the market. Additionally, the rise in population, urbanization, the surge in healthcare expenditure and developing healthcare infrastructure positively affects the uremia treatment market. Furthermore, research and development and enhancement in dialysis extend profitable opportunities to the market players in the forecast period of 2021 to 2028.

On the other hand, the high cost associated with the treatment and dialysis is expected to obstruct the market growth. Lack of awareness and stringent regulations are projected to challenge the uremia treatment market in the forecast period of 2021-2028.

This uremia treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info uremia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Uremia Treatment Market Scope and Market Size

The uremia treatment market is segmented on the basis of treatment type, drug type, mode of administration, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment type, the uremia treatment market is segmented into hemodialysis and peritoneal dialysis.
• On the basis of drug type, the uremia treatment market is segmented into potassium-sparing diuretics, angiotensin-converting enzymes (ace) inhibitors, angiotensin-receptor blockers, beta blockers, NSAIDS, oral anticoagulants or antiplatelet and others.
• On the basis of mode of administration, the uremia treatment market is segmented into injectable, oral and others.
• On the basis of distribution channel, the uremia treatment market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
• On the basis of end user, the uremia treatment market is segmented into hospitals, homecare, specialty clinics and other.

Global Uremia Treatment Market Country Level Analysis

The uremia treatment market is analyzed and market size information is provided by country, treatment type, drug type, mode of administration, distribution channel and end user as referenced above.

The countries covered in the global uremia treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the uremia treatment market due to the rise in the incidence of diabetes and high blood pressure within the region. Asia-Pacific, excluding Japan and the Latin American region, is expected to witness significant growth during the forecast period of 2021 to 2028 because of the large patient population, the number of end users, and increased awareness about kidney-related diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The uremia treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Uremia Treatment Market Share Analysis

요독증 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 회사의 초점 관련 요독증 치료 시장에만 관련이 있습니다.

요독증 치료 시장 보고서에 포함된 주요 기업으로는 Amgen Inc., Alkem Labs, LUPIN, Hope Pharmaceuticals, Sanifit, BSN medical, Sun Pharmaceutical Industries Ltd, Cipla Inc., Mylan NV Teva Pharmaceutical Industries Ltd, Zydus Cadila 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-62964